The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Apatinib as second-line therapy in Chinese patients with advanced hepatocellular carcinoma: A randomized, placebo-controlled, double-blind, phase III study.
 
Qiu Li
No Relationships to Disclose
 
Shukui Qin
No Relationships to Disclose
 
Shanzhi Gu
No Relationships to Disclose
 
Xiaoming Chen
No Relationships to Disclose
 
Lizhu Lin
No Relationships to Disclose
 
Zishu Wang
No Relationships to Disclose
 
Aibing Xu
No Relationships to Disclose
 
Xi Chen
No Relationships to Disclose
 
Cuncai Zhou
No Relationships to Disclose
 
Zhenggang Ren
No Relationships to Disclose
 
Lin Yang
No Relationships to Disclose
 
Li Xu
No Relationships to Disclose
 
Yuxian Bai
No Relationships to Disclose
 
Lei Chen
No Relationships to Disclose
 
Jun Li
No Relationships to Disclose
 
Hongming Pan
No Relationships to Disclose
 
Bangwei Cao
No Relationships to Disclose
 
Weijia Fang
No Relationships to Disclose
 
Ping Yan
Employment - Jiangsu Hengrui Medicine
 
Chunlei Jin
Employment - Jiangsu Hengrui Medicine